{
  "meta": {
    "title": "Neet_Pg_2024",
    "url": "https://brainandscalpel.vercel.app/neet-pg-2024-d0876eb3.html",
    "scrapedAt": "2025-11-30T07:35:25.343Z"
  },
  "questions": [
    {
      "id": 1,
      "choices": [
        {
          "id": 1,
          "text": "<p><span style=\"font-size:12.0pt;\">Myxomatous Polyp</span></p>"
        },
        {
          "id": 2,
          "text": "<p><span style=\"font-size:12.0pt;\">Uterine Inversion</span></p>"
        },
        {
          "id": 3,
          "text": "<p><span style=\"font-size:12.0pt;\">Placental Polyp</span></p>"
        },
        {
          "id": 4,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypertrophied Cervix</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 50-year-old woman, who had her last pregnancy 20 years ago, presents with heavy bleeding and a mass felt on the perineum. A smooth, round, globular structure is observed on examination. On bimanual examination, the uterus is firm, and the cervix admits one finger. What is the most likely diagnosis?</span></p>",
      "unique_key": "DT1325045",
      "question_audio": null,
      "question_video": null,
      "map_id": 1325045,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>A <strong>myxomatous (fibroid) polyp</strong> is a benign <strong>leiomyoma</strong> that can prolapse through the cervix, presenting as a smooth mass with a firm uterus and abnormal bleeding years after delivery.</p>\r\n<ul>\r\n<li>Myxomatous polyps (also called fibroid polyps or prolapsed submucous fibroids) are benign smooth muscle tumors of the uterus that can protrude through the cervix and present as a mass at the introitus or perineum.</li>\r\n<li>In this case, the key findings include:\r\n<ul>\r\n<li>Smooth, round, globular mass on perineal examination</li>\r\n<li>Palpable, firm uterus on bimanual exam</li>\r\n<li>Cervix admitting one finger (suggesting something protruding through the cervix)</li>\r\n</ul>\r\n</li>\r\n<li>This constellation strongly suggests a prolapsed submucous fibroid (i.e., a myxomatous polyp), especially in a woman long past childbearing age.</li>\r\n</ul>\r\n<p><strong>Leiomyoma:</strong></p>\r\n<ul>\r\n<li>Leiomyomas are non-cancerous tumors composed of smooth muscle cells that arise from the myometrium.</li>\r\n<li><strong>Clinical Features</strong>:\r\n<ul>\r\n<li>Asymptomatic in ~75%: Often discovered incidentally</li>\r\n<li>Abnormal Uterine Bleeding (AUB) in ~30%: Includes menorrhagia and metrorrhagia</li>\r\n<li>Pelvic pain symptoms: Dysmenorrhea, dyspareunia</li>\r\n<li>Reproductive issues: Infertility</li>\r\n<li>Pressure effects: Increased urinary frequency or retention, constipation</li>\r\n<li>Sensation of heaviness: Lower abdominal or pelvic discomfort</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>Uterine Inversion (Option B):</strong> Occurs acutely postpartum, not decades after delivery. It presents with severe pain, hemorrhage, and shock-not seen here.</p>\r\n<p><strong>Placental Polyp (Option C):</strong> Retained placental tissue occurs shortly after delivery or abortion. It is highly unlikely 20 years post-childbirth.</p>\r\n<p><strong>Hypertrophied Cervix (Option D):</strong> Refers to generalized cervical enlargement, not a discrete globular mass at the perineum. The presence of a protruding mass with a separate firm uterus rules this out.</p>",
      "correct_choice_id": 1,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2,
      "choices": [
        {
          "id": 11,
          "text": "<p><span style=\"font-size:12.0pt;\">Superfetation</span></p>"
        },
        {
          "id": 12,
          "text": "<p><span style=\"font-size:12.0pt;\">Superfecundation</span></p>"
        },
        {
          "id": 13,
          "text": "<p><span style=\"font-size:12.0pt;\">Suppositious child</span></p>"
        },
        {
          "id": 14,
          "text": "<p><span style=\"font-size:12.0pt;\">Posthumous child</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A woman presents with a twin pregnancy. On ultrasound, the estimated age of one fetus is 1 month more than the other fetus.</span></p>",
      "unique_key": "DT1325046",
      "question_audio": null,
      "question_video": null,
      "map_id": 1325046,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p><strong>Superfetation</strong> is the fertilization of two ova in different menstrual cycles, leading to a significant gestational age difference between twins.</p>\r\n<ul>\r\n<li>Superfetation refers to the conception of a second fetus during an ongoing pregnancy, caused by ovulation and fertilization occurring in a separate menstrual cycle.</li>\r\n<li>It is an extremely rare phenomenon in humans due to hormonal and physiological changes that usually prevent further ovulation and implantation once pregnancy begins.</li>\r\n<li>In reported cases, it results in fetuses with a clear age gap, such as one fetus being a month older than the other, as described in this scenario.</li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>Superfecundation (Option B):</strong> Fertilization of two ova during the same cycle from separate acts of intercourse, possibly with different fathers. Twins are of the same gestational age.</p>\r\n<p><strong>Suppositious child (Option C):</strong> A fictitious or fraudulently presented child, often introduced to claim inheritance or lineage rights.</p>\r\n<p><strong>Posthumous child (Option D):</strong> A child born after the death of the biological father, but conceived while he was still alive.</p>",
      "correct_choice_id": 11,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3,
      "choices": [
        {
          "id": 21,
          "text": "<p><span style=\"font-size:12.0pt;\">Fothergill surgery</span></p>"
        },
        {
          "id": 22,
          "text": "<p><span style=\"font-size:12.0pt;\">McCall culdoplasty</span></p>"
        },
        {
          "id": 23,
          "text": "<p><span style=\"font-size:12.0pt;\">LeFort's repair</span></p>"
        },
        {
          "id": 24,
          "text": "<p><span style=\"font-size:12.0pt;\">Hysterectomy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 30-year-old female, P2L2, with a history of infravaginal cervical lengthening, is considering surgical options.</span></p>",
      "unique_key": "DT1325047",
      "question_audio": null,
      "question_video": null,
      "map_id": 1325047,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p><strong>Fothergill surgery</strong> (also known as <strong>Manchester repair</strong>) is ideal for young women under 40 years with cervical elongation and uterine prolapse who wish to preserve fertility.</p>\r\n<ul>\r\n<li>Fothergill surgery is specifically indicated in women with uterine prolapse who desire uterine conservation, especially when associated with infravaginal cervical elongation.</li>\r\n<li>It is appropriate for younger women (typically &lt;40 years) who have completed their families or wish to preserve reproductive potential.</li>\r\n<li>The procedure involves:\r\n<ul>\r\n<li>Amputation of the elongated cervix</li>\r\n<li>Plication of the Mackenrodt's (cardinal) ligaments to support the uterus</li>\r\n<li>Anterior colporrhaphy and colpoperineorrhaphy for vaginal wall support</li>\r\n</ul>\r\n</li>\r\n<li>This combination restores normal anatomy while retaining the uterus, which aligns with the needs of a young woman with cervical elongation.</li>\r\n<li><strong>Complications</strong> include:\r\n<ul>\r\n<li>Cervical stenosis</li>\r\n<li>Fibrosis</li>\r\n<li>Cervical incompetence (if future pregnancy occurs)</li>\r\n<li>Urinary retention</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>McCall culdoplasty (Option B):</strong> Used to prevent enterocele by suspending the vaginal apex, typically performed during or after hysterectomy-not suitable for patients needing cervical correction or uterine conservation.</p>\r\n<p><strong>LeFort's repair (Option C):</strong> A partial colpocleisis reserved for elderly women with advanced prolapse who are unfit for more extensive surgery and do not desire future sexual activity or fertility.</p>\r\n<p><strong>Hysterectomy (Option D):</strong> Although definitive, it's inappropriate here given the patient's age and her need for uterine preservation due to prior cervical surgery and reproductive considerations.</p>",
      "correct_choice_id": 21,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4,
      "choices": [
        {
          "id": 31,
          "text": "<p><span style=\"font-size:12.0pt;\">Sacral promontory</span></p>"
        },
        {
          "id": 32,
          "text": "<p><span style=\"font-size:12.0pt;\">Ischial spine</span></p>"
        },
        {
          "id": 33,
          "text": "<p><span style=\"font-size:12.0pt;\">Pubic symphysis</span></p>"
        },
        {
          "id": 34,
          "text": "<p><span style=\"font-size:12.0pt;\">Ischial tuberosity</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">In sacrocolpopexy (sacrocolposuspension), which is the correct site of attachment of the mesh?</span></p>",
      "unique_key": "DT1325048",
      "question_audio": null,
      "question_video": null,
      "map_id": 1325048,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>In <strong>sacrocolpopexy</strong>, the mesh is anchored to the anterior longitudinal ligament over the sacral promontory to provide durable support to the vaginal vault or uterus.</p>\r\n<ul>\r\n<li><strong>Sacrocolpopexy</strong> is a surgical procedure performed for <strong>vault prolapse</strong> or <strong>uterine prolapse</strong>, particularly when uterine preservation is desired or following hysterectomy.</li>\r\n<li>It is often performed abdominally or laparoscopically.</li>\r\n<li>In this procedure, a synthetic mesh is used to suspend the vaginal apex (or uterus) to the anterior longitudinal ligament over the sacral promontory-a strong anchoring point on the anterior surface of the sacrum at the lumbosacral junction.</li>\r\n<li>This provides physiologic and durable support, preserving the axis of the vagina and minimizing prolapse recurrence.</li>\r\n<li>It is preferred in sexually active women and those desiring anatomical and functional restoration.</li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>Ischial spine (Option B):</strong> While it's an anatomical landmark for procedures like uterosacral ligament suspension, it is not the site for mesh attachment in sacrocolpopexy.</p>\r\n<p><strong>Pubic symphysis (Option C):</strong> Lies anteriorly and has no role in pelvic organ prolapse surgeries involving vault suspension.</p>\r\n<p><strong>Ischial tuberosity (Option D):</strong> Serves as the origin for hamstring muscles and is unrelated to any pelvic organ prolapse surgical mesh fixation.</p>",
      "correct_choice_id": 31,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5,
      "choices": [
        {
          "id": 41,
          "text": "<p><span style=\"font-size:12.0pt;\">Check for congenital anomalies, sex of baby, but do not reveal gender to the patient</span></p>"
        },
        {
          "id": 42,
          "text": "<p><span style=\"font-size:12.0pt;\">Check for congenital anomalies, do not check the sex of the fetus</span></p>"
        },
        {
          "id": 43,
          "text": "<p><span style=\"font-size:12.0pt;\">Check for congenital anomalies, sex of baby and reveal gender if it is female</span></p>"
        },
        {
          "id": 44,
          "text": "<p><span style=\"font-size:12.0pt;\">Check only routine ANC, and avoid USG</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A G5P4 woman comes for her first routine sonography. She has four daughters and desires a boy this time, and asks to know the sex of the fetus. According to the PCPNDT Act, which action should a radiologist choose?</span></p>",
      "unique_key": "DT1325049",
      "question_audio": null,
      "question_video": null,
      "map_id": 1325049,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>Under the <strong>PCPNDT Act</strong>, fetal sex determination is prohibited, and the radiologist must focus solely on assessing congenital anomalies without attempting to determine fetal gender.</p>\r\n<ul>\r\n<li>The <strong>Pre-Conception and Pre-Natal Diagnostic Techniques (PCPNDT) Act</strong>, enacted in India in 1994 and amended in 2003, was introduced to combat female feticide and address the declining sex ratio.</li>\r\n<li>It strictly prohibits sex selection and sex determination before or after conception.</li>\r\n<li>During routine prenatal ultrasounds, a radiologist is legally obligated to examine fetal growth, viability, and congenital anomalies but is prohibited from determining or recording the fetal sex.</li>\r\n<li>Violating this can lead to severe penalties, including suspension of medical license and criminal prosecution.</li>\r\n<li>In this case, despite the patient's request due to personal bias (having four daughters), the radiologist must maintain ethical and legal integrity by not attempting to determine or disclose the fetal gender.</li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>Check for congenital anomalies, sex of baby, but do not reveal gender to the patient (Option A):</strong> Even if the sex is not revealed, determining the sex itself is illegal under the PCPNDT Act, unless it's done under specific medical indications (which are rare).</p>\r\n<p><strong>Check for congenital anomalies, sex of baby and reveal gender if it is female (Option C):</strong> This clearly violates the PCPNDT Act by both determining and disclosing the sex of the fetus, regardless of gender.</p>\r\n<p><strong>Check only routine ANC, and avoid USG (Option D):</strong> Avoiding ultrasound altogether is not appropriate, as it is essential for routine antenatal care, especially for detecting fetal anomalies.</p>\r\n<p><strong>Reference:</strong><a href=\"https://pmc.ncbi.nlm.nih.gov/articles/PMC3498638/\">https://pmc.ncbi.nlm.nih.gov/articles/PMC3498638/</a></p>",
      "correct_choice_id": 42,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6,
      "choices": [
        {
          "id": 51,
          "text": "<p><span style=\"font-size:12.0pt;\">Methyl ergometrine</span></p>"
        },
        {
          "id": 52,
          "text": "<p><span style=\"font-size:12.0pt;\">Carboprost</span></p>"
        },
        {
          "id": 53,
          "text": "<p><span style=\"font-size:12.0pt;\">Misoprostol</span></p>"
        },
        {
          "id": 54,
          "text": "<p><span style=\"font-size:12.0pt;\">Oxytocin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A pregnant woman with bronchial asthma develops postpartum hemorrhage (PPH) during delivery of her first child. Which drug is contraindicated?</span></p>",
      "unique_key": "DT1325050",
      "question_audio": null,
      "question_video": null,
      "map_id": 1325050,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p><strong>Carboprost</strong> is contraindicated in asthma due to its bronchoconstrictive properties, which can trigger life-threatening asthma exacerbations.</p>\r\n<ul>\r\n<li>Carboprost is a synthetic analogue of Prostaglandin F2&alpha; (PGF2&alpha;), used in the management of refractory PPH due to uterine atony.</li>\r\n<li>However, it induces bronchial smooth muscle contraction, making it dangerous in patients with asthma.</li>\r\n<li>Dose: 250 &micro;g IM every 15-90 mins, up to a maximum of 2 mg.</li>\r\n<li>Efficacy: Very effective in controlling uterine bleeding (~88%).</li>\r\n<li>Side effects: Bronchospasm, diarrhea, hypertension, fever, nausea, vomiting.</li>\r\n<li>Absolute Contraindications: Asthma, pulmonary hypertension, amniotic fluid embolism.</li>\r\n<li>Relative Contraindications: Cardiac disease, liver/renal dysfunction, preeclampsia.</li>\r\n<li>In asthmatic patients, using carboprost could lead to bronchoconstriction and respiratory distress, which can be fatal.</li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>Methyl ergometrine (Option A):</strong> Causes vasoconstriction and is contraindicated in hypertension, not asthma. It&rsquo;s relatively safe in asthmatic patients if blood pressure is controlled.</p>\r\n<p><strong>Misoprostol (Option C):</strong> A Prostaglandin E1 analogue. It does not cause bronchoconstriction, making it safe in asthma. Used rectally, orally, or sublingually for PPH.</p>\r\n<p><strong>Oxytocin (Option D):</strong> First-line agent for PPH. Promotes uterine contraction by acting on oxytocin receptors. It&rsquo;s safe in asthma, with no bronchial side effects.</p>\r\n<p><strong>Reference:</strong></p>\r\n<p><a href=\"https://www.uptodate.com/contents/postpartum-hemorrhage-medical-and-minimally-invasive-management?search=postpartum%20hemorrhage%20management&amp;source=search_result&amp;selectedTitle=2~150&amp;usage_type=default&amp;display_rank=2#H187794904\">https://www.uptodate.com/contents/postpartum-hemorrhage-medical-and-minimally-invasive-management?search=postpartum%20hemorrhage%20management&amp;source=search_result&amp;selectedTitle=2~150&amp;usage_type=default&amp;display_rank=2#H187794904</a></p>",
      "correct_choice_id": 52,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7,
      "choices": [
        {
          "id": 61,
          "text": "<p><span style=\"font-size:12.0pt;\">Stage II B</span></p>"
        },
        {
          "id": 62,
          "text": "<p><span style=\"font-size:12.0pt;\">Stage II A</span></p>"
        },
        {
          "id": 63,
          "text": "<p><span style=\"font-size:12.0pt;\">Stage III B</span></p>"
        },
        {
          "id": 64,
          "text": "<p><span style=\"font-size:12.0pt;\">Stage III A</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient with cervical cancer is found to have pelvic sidewall involvement and hydronephrosis on evaluation. What is the stage?</span></p>",
      "unique_key": "DT1325051",
      "question_audio": null,
      "question_video": null,
      "map_id": 1325051,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>Stage III B cervical cancer is defined by pelvic sidewall involvement and/or hydronephrosis, both of which are present in this patient.</p>\r\n<ul>\r\n<li>The FIGO 2018 staging system for cervical cancer emphasizes anatomical spread, including the pelvic sidewall and hydronephrosis as critical criteria for Stage III B.</li>\r\n<li>Stage III B:\r\n<ul>\r\n<li>Tumor extends to the pelvic sidewall</li>\r\n<li>And/or causes hydronephrosis or non-functioning kidney (not due to other causes)</li>\r\n</ul>\r\n</li>\r\n<li>In this patient:\r\n<ul>\r\n<li>Pelvic sidewall involvement &rarr; suggests extensive local invasion.</li>\r\n<li>Hydronephrosis &rarr; due to ureteral compression/obstruction by tumor, a hallmark of advanced disease.</li>\r\n</ul>\r\n</li>\r\n<li>Hence, the diagnosis is Stage III B cervical cancer.</li>\r\n</ul>\r\n<p><strong>FIGO staging of cervical cancer:</strong></p><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250828be711412-b829-4cf2-95d4-d648e887f2fe.png\">\r\n<p><strong>Reference:</strong></p>\r\n<p><a href=\"https://radiopaedia.org/articles/cervical-cancer-staging-1\">https://radiopaedia.org/articles/cervical-cancer-staging-1</a></p>",
      "correct_choice_id": 63,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8,
      "choices": [
        {
          "id": 71,
          "text": "<p><span style=\"font-size:12.0pt;\">LSCS (Lower Segment Caesarean Section)</span></p>"
        },
        {
          "id": 72,
          "text": "<p><span style=\"font-size:12.0pt;\">Classic Caesarean Section</span></p>"
        },
        {
          "id": 73,
          "text": "<p><span style=\"font-size:12.0pt;\">Vaginal Delivery</span></p>"
        },
        {
          "id": 74,
          "text": "<p><span style=\"font-size:12.0pt;\">Induction of Labour</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A pregnant woman presents in labor with active genital ulcers, likely of infectious etiology such as Herpes Simplex Virus (HSV).</span></p>",
      "unique_key": "DT1325052",
      "question_audio": null,
      "question_video": null,
      "map_id": 1325052,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p><strong>LSCS </strong>is recommended to prevent vertical transmission of infection (especially HSV) from mother to neonate during vaginal delivery in the presence of active genital ulcers.</p>\r\n<ul>\r\n<li>Genital ulcers in pregnancy are often caused by HSV-2.</li>\r\n<li>If the mother has active lesions at the time of delivery, vertical transmission of the virus can occur, leading to neonatal herpes, which has high morbidity and mortality.</li>\r\n<li>Neonatal herpes can manifest as:\r\n<ul>\r\n<li>Localized skin, eye, mouth (SEM) infection</li>\r\n<li>Disseminated infection</li>\r\n<li>Central nervous system involvement</li>\r\n</ul>\r\n</li>\r\n<li>To prevent transmission:\r\n<ul>\r\n<li>LSCS is the preferred mode of delivery when active lesions or prodromal symptoms are present at the time of labor.</li>\r\n</ul>\r\n</li>\r\n<li>Timing: LSCS is ideally performed within 4-6 hours of membrane rupture to minimize viral exposure.</li>\r\n</ul>\r\n<p><strong>Indications for Cesarean Delivery:</strong></p><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250828460b4edc-e0f5-4c37-9cd4-400e9333ae07.png\">\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>Classic Caesarean Section (Option B): </strong>Involves a vertical uterine incision, reserved for rare indications (e.g., transverse lie with back down, placenta previa, or lower uterine segment not developed). Not indicated for genital ulcers.</p>\r\n<p><strong>Vaginal Delivery (Option C): </strong>Contraindicated in active genital herpes or suspicious ulcers due to high risk of neonatal HSV infection.</p>\r\n<p><strong>Induction of Labour (Option D): </strong>Inducing labor increases risk of prolonged exposure to infection, making it unsafe in the presence of active genital ulcers.</p>",
      "correct_choice_id": 71,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9,
      "choices": [
        {
          "id": 81,
          "text": "<p><span style=\"font-size:12.0pt;\">Android</span></p>"
        },
        {
          "id": 82,
          "text": "<p><span style=\"font-size:12.0pt;\">Gynecoid</span></p>"
        },
        {
          "id": 83,
          "text": "<p><span style=\"font-size:12.0pt;\">Anthropoid</span></p>"
        },
        {
          "id": 84,
          "text": "<p><span style=\"font-size:12.0pt;\">Platypelloid</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Persistent occipito-posterior (OP) face-to-pubis delivery is most likely to be seen in which pelvic type?</span></p>",
      "unique_key": "DT1325053",
      "question_audio": null,
      "question_video": null,
      "map_id": 1325053,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>Persistent occipito-posterior (OP) and face-to-pubis deliveries are most commonly associated with the anthropoid pelvis, due to its elongated anteroposterior diameter.</p>\r\n<ul>\r\n<li>The anthropoid pelvis has:\r\n<ul>\r\n<li>An oval-shaped inlet elongated in the anteroposterior direction</li>\r\n<li>Straight side walls, wide sacrosciatic notches</li>\r\n<li>A narrow subpubic angle</li>\r\n</ul>\r\n</li>\r\n<li>This configuration:\r\n<ul>\r\n<li>Favors the occiput of the fetus remaining posterior rather than rotating anteriorly</li>\r\n<li>Makes persistent OP positions and face-to-pubis deliveries more likely</li>\r\n<li>These deliveries are usually longer and more difficult due to malrotation and the need for greater head flexion or deflexion</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Pelvic Types and Common Presentations:</strong></p><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202508280a24a338-9259-45ed-af25-6629b2e83e3d.png\"><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250828b929a2d1-7eb6-4a54-88f1-a8422604742e.png\">",
      "correct_choice_id": 83,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10,
      "choices": [
        {
          "id": 91,
          "text": "<p><span style=\"font-size:12.0pt;\">Anencephaly</span></p>"
        },
        {
          "id": 92,
          "text": "<p><span style=\"font-size:12.0pt;\">Hydranencephaly</span></p>"
        },
        {
          "id": 93,
          "text": "<p><span style=\"font-size:12.0pt;\">Spina Bifida</span></p>"
        },
        {
          "id": 94,
          "text": "<p><span style=\"font-size:12.0pt;\">Lissencephaly</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the most likely diagnosis based on the ultrasound finding in the given image?<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250828f771f9f1-e8a6-411f-8409-ef6e572c3d66.png\"></span></p>",
      "unique_key": "DT1325054",
      "question_audio": null,
      "question_video": null,
      "map_id": 1325054,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>Anencephaly presents on ultrasound as absence of the cranial vault with exposed brain tissue and the classic \"frog eye\" sign, making it the most likely diagnosis.</p>\r\n<ul>\r\n<li>Anencephaly is a lethal neural tube defect (NTD) resulting from failure of closure of the rostral (cranial) end of the neural tube around the 25th day of embryonic development.</li>\r\n<li><strong>Ultrasound Features</strong>:\r\n<ul>\r\n<li>Absence of cranial vault and calvarium</li>\r\n<li>Absent cerebral hemispheres</li>\r\n<li>Presence of bulging orbits, giving the classic \"frog eye\" appearance</li>\r\n<li>Detected as early as 11-14 weeks in antenatal scans</li>\r\n</ul>\r\n</li>\r\n<li><strong>Pathophysiology</strong>:\r\n<ul>\r\n<li>Failure of cranial neuropore closure &rarr; defective skull formation</li>\r\n<li>Brain tissue is exposed and degenerates due to amniotic fluid exposure</li>\r\n</ul>\r\n</li>\r\n<li><strong>Prognosis</strong>:\r\n<ul>\r\n<li>Lethal condition; most fetuses are stillborn or die shortly after birth</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>Hydranencephaly (Option B):</strong> Cerebral hemispheres are replaced by CSF, but the skull and cranial bones are present. There is no frog eye appearance.</p>\r\n<p><strong>Spina Bifida (Option C):</strong> A neural tube defect affecting the spine, not the brain. It presents with signs like <strong>lemon sign</strong> (scalloping of frontal bones) and <strong>banana sign</strong> (curved cerebellum) on ultrasound, not absence of cranial vault.</p><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250828ce3d784e-831b-4575-bcb4-f506292ad0dc.png\">\r\n<p><strong>Lissencephaly (Option D):</strong> A disorder of neuronal migration causing a smooth brain surface, seen later in gestation or postnatally; cranial bones are present, and there's no frog eye sign.</p>",
      "correct_choice_id": 91,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11,
      "choices": [
        {
          "id": 101,
          "text": "<p><span style=\"font-size:12.0pt;\">Mifepristone and Misoprostol</span></p>"
        },
        {
          "id": 102,
          "text": "<p><span style=\"font-size:12.0pt;\">Dinoprostone</span></p>"
        },
        {
          "id": 103,
          "text": "<p><span style=\"font-size:12.0pt;\">Oxytocin</span></p>"
        },
        {
          "id": 104,
          "text": "<p><span style=\"font-size:12.0pt;\">Intrauterine hyperosmolar saline</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A woman presents at 10 weeks of gestation and seeks medical termination of pregnancy (MTP). The appropriate choice would be?</span></p>",
      "unique_key": "DT1325055",
      "question_audio": null,
      "question_video": null,
      "map_id": 1325055,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>The combination of <strong>Mifepristone and Misoprostol</strong> is the safest and most effective method for medical abortion up to 10 weeks of gestation.</p>\r\n<ul>\r\n<li>For first-trimester medical termination (up to 10 weeks POG), the standard regimen includes:\r\n<ul>\r\n<li>Mifepristone 200 mg orally: An antiprogesterone that sensitizes the myometrium to prostaglandins by blocking progesterone support to the pregnancy.</li>\r\n<li>Followed by Misoprostol 800 mcg vaginally or sublingually 24-48 hours later: A prostaglandin E1 analogue that induces uterine contractions to expel the pregnancy.</li>\r\n</ul>\r\n</li>\r\n<li>Why this regimen?\r\n<ul>\r\n<li>High efficacy (&gt;95%)</li>\r\n<li>Non-invasive</li>\r\n<li>Can be used safely in outpatient settings</li>\r\n<li>Low complication rate</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Medical Abortion Regimens Summary:</strong></p><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250828f7ae17e6-fec9-4144-9f93-2b6cc721f4e7.png\">\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>Dinoprostone (Option B):</strong> Prostaglandin E2 is used mainly in second-trimester abortion or labor induction, not first-trimester MTP.</p>\r\n<p><strong>Oxytocin (Option C):</strong> Effective only in later gestation when oxytocin receptors are more abundant. Not used in the early first trimester for abortion.</p>\r\n<p><strong>Intrauterine Hyperosmolar Saline (Option D):</strong> Outdated method used for mid-trimester abortions; carries risk of complications like DIC and is not used today for early pregnancy termination.</p>",
      "correct_choice_id": 101,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12,
      "choices": [
        {
          "id": 111,
          "text": "<p><span style=\"font-size:12.0pt;\">Placenta accreta syndrome</span></p>"
        },
        {
          "id": 112,
          "text": "<p><span style=\"font-size:12.0pt;\">Uterine inversion</span></p>"
        },
        {
          "id": 113,
          "text": "<p><span style=\"font-size:12.0pt;\">Abruptio placenta</span></p>"
        },
        {
          "id": 114,
          "text": "<p><span style=\"font-size:12.0pt;\">Placenta previa</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A G2P1L1 woman with a previous LSCS presents with antepartum hemorrhage (APH) and required obstetric hysterectomy. A specimen (placenta invading uterine wall) is provided. What is the most likely diagnosis based on clinical history and the specimen image?<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250828e99df93c-3076-4865-a11d-5ae2fb6e102b.png\"></span></p>",
      "unique_key": "DT1325056",
      "question_audio": null,
      "question_video": null,
      "map_id": 1325056,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p><strong>Placenta accreta syndrome</strong> involves abnormal placental adherence to the uterine wall, often necessitating hysterectomy when separation fails, especially in scarred uteri from prior LSCS.</p>\r\n<ul>\r\n<li><strong>Placenta Accreta Syndrome</strong> (<strong>PAS</strong>) is a serious condition where the placenta invades too deeply into the uterine wall, often due to a defective decidua basalis and absence of the Nitabuch layer.</li>\r\n<li>It is strongly associated with:\r\n<ul>\r\n<li>Previous cesarean section</li>\r\n<li>Placenta previa</li>\r\n<li>Uterine surgery/scarring</li>\r\n</ul>\r\n</li>\r\n<li>In PAS, manual separation fails, leading to massive hemorrhage, requiring life-saving obstetric hysterectomy.\r\n<ul>\r\n<li>Placenta Accreta Spectrum Variants:</li>\r\n<li>Placenta accreta: Chorionic villi adhere to endometrium</li>\r\n<li>Placenta increta: Invade into the myometrium</li>\r\n<li>Placenta percreta: Penetrate through serosa, possibly bladder<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250828fcb773cb-d579-4282-8409-1fc0a78fc9ca.png\"></li>\r\n</ul>\r\n</li>\r\n<li>Management:\r\n<ul>\r\n<li>Total PAS (e.g., increta/percreta): Immediate hysterectomy, especially in patients with completed family</li>\r\n<li>Partial PAS: Attempt conservative management (oxytocics, embolization, MTX)</li>\r\n<li>Complicated PAS (e.g., bladder invasion): Hysterectomy with partial cystectomy if needed</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>Uterine inversion (Option B): </strong>Involves turning inside-out of uterus after delivery. Not related to LSCS history or hysterectomy specimens.</p>\r\n<p><strong>Abruptio placenta (Option C):</strong> Premature placental separation. Does not require hysterectomy, nor show placental adherence to the uterine wall.</p>\r\n<p><strong>Placenta previa (Option D):</strong> Placenta covers cervix &rarr; painless APH. Managed via cesarean, not typically associated with hysterectomy or placental invasion.</p>",
      "correct_choice_id": 111,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13,
      "choices": [
        {
          "id": 121,
          "text": "<p><span style=\"font-size:12.0pt;\">Secondary oocyte arrested in meiosis I</span></p>"
        },
        {
          "id": 122,
          "text": "<p><span style=\"font-size:12.0pt;\">Secondary oocyte arrested in meiosis II</span></p>"
        },
        {
          "id": 123,
          "text": "<p><span style=\"font-size:12.0pt;\">Primary oocyte arrested in meiosis I</span></p>"
        },
        {
          "id": 124,
          "text": "<p><span style=\"font-size:12.0pt;\">Primary oocyte arrested in meiosis II</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">After ovulation, the egg is released from the ovary. At what stage of meiosis is the released egg arrested?</span></p>",
      "unique_key": "DT1325057",
      "question_audio": null,
      "question_video": null,
      "map_id": 1325057,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>After ovulation, the secondary oocyte is arrested in metaphase II of meiosis II until fertilization occurs.</p>\r\n<p><strong>Oogenesis Timeline</strong></p>\r\n<ul>\r\n<li>Fetal life:\r\n<ul>\r\n<li>Oogonia undergo mitosis and begin meiosis I, becoming primary oocytes which are arrested in prophase I (diplotene stage) until puberty.</li>\r\n</ul>\r\n</li>\r\n<li>Puberty (monthly cycle):\r\n<ul>\r\n<li>Each month, under LH surge, one primary oocyte completes meiosis I, forming:\r\n<ul>\r\n<li>A secondary oocyte (larger cell)</li>\r\n<li>A first polar body (smaller, non-functional)</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n</li>\r\n<li>Ovulation:\r\n<ul>\r\n<li>The secondary oocyte is released and enters meiosis II, but it is arrested in metaphase II.</li>\r\n</ul>\r\n</li>\r\n<li>After Fertilization:\r\n<ul>\r\n<li>Meiosis II completes only if sperm penetrates:\r\n<ul>\r\n<li>Formation of mature ovum</li>\r\n<li>Release of second polar body</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n</li>\r\n<li>If fertilization doesn't occur, the oocyte remains in metaphase II and degenerates within 24 hours.<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250828c5975ec3-a714-46b6-8ce9-f314cb94698b.png\"></li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>Secondary oocyte arrested in meiosis I (Option A):</strong> Incorrect - the secondary oocyte forms after completion of meiosis I; hence, cannot be arrested in meiosis I.</p>\r\n<p><strong>Primary oocyte arrested in meiosis I (Option C):</strong> Incorrect - this arrest occurs before puberty, not after ovulation. The ovulated cell is a secondary oocyte, not a primary oocyte.</p>\r\n<p><strong>Primary oocyte arrested in meiosis II (Option D):</strong> Incorrect - primary oocytes never enter meiosis II. Only secondary oocytes do that after completing meiosis I.</p>",
      "correct_choice_id": 122,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14,
      "choices": [
        {
          "id": 131,
          "text": "<p><span style=\"font-size:12.0pt;\">3 cm posterior to the anterior fontanelle</span></p>"
        },
        {
          "id": 132,
          "text": "<p><span style=\"font-size:12.0pt;\">3 cm anterior to the posterior fontanelle</span></p>"
        },
        {
          "id": 133,
          "text": "<p><span style=\"font-size:12.0pt;\">6 cm anterior to the posterior fontanelle</span></p>"
        },
        {
          "id": 134,
          "text": "<p><span style=\"font-size:12.0pt;\">Midway between the anterior and posterior fontanelle</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">You're assisting with a ventouse (vacuum-assisted) delivery in a primigravida woman due to maternal exhaustion. The obstetrician instructs you to place the ventouse cup correctly. Where should the ventouse cup be placed?</span></p>",
      "unique_key": "DT1325058",
      "question_audio": null,
      "question_video": null,
      "map_id": 1325058,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>The ideal placement for the ventouse cup is at the flexion point, which lies 3 cm anterior to the posterior fontanelle along the sagittal suture.</p>\r\n<ul>\r\n<li>The flexion point is key in vacuum-assisted deliveries.</li>\r\n<li>It lies on the sagittal suture, exactly 3 cm in front of the posterior fontanelle.</li>\r\n<li>This point corresponds to the optimal location for the ventouse cup to facilitate delivery.</li>\r\n<li>Why this location?\r\n<ul>\r\n<li>Promotes maximum flexion of the fetal head.</li>\r\n<li>Allows passage of the smallest diameter (suboccipitobregmatic, ~9.5 cm) through the birth canal.</li>\r\n<li>Ensures effective traction, reducing risks of:\r\n<ul>\r\n<li>Cup detachment</li>\r\n<li>Head deflexion</li>\r\n<li>Prolonged labor or injury</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n</li>\r\n<li>Ventouse is typically used in:\r\n<ul>\r\n<li>Prolonged second stage</li>\r\n<li>Maternal exhaustion</li>\r\n<li>Non-reassuring fetal heart rate patterns (in certain settings)<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250828b5923fed-aa40-414f-80fb-4a8816554578.png\"></li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>3 cm posterior to the anterior fontanelle (Option A):</strong> Incorrect - this is not equivalent to the flexion point and may result in deflexion of the fetal head during traction.</p>\r\n<p><strong>6 cm anterior to the posterior fontanelle (Option C):</strong> Incorrect - this places the cup near the anterior fontanelle, which compromises proper flexion.</p>\r\n<p><strong>Midway between the anterior and posterior fontanelle (Option D):</strong> Incorrect - although central, this is not the flexion point and may reduce the efficiency of traction.</p>",
      "correct_choice_id": 132,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15,
      "choices": [
        {
          "id": 141,
          "text": "<p><span style=\"font-size:12.0pt;\">Warfarin</span></p>"
        },
        {
          "id": 142,
          "text": "<p><span style=\"font-size:12.0pt;\">Heparin</span></p>"
        },
        {
          "id": 143,
          "text": "<p><span style=\"font-size:12.0pt;\">Apixaban</span></p>"
        },
        {
          "id": 144,
          "text": "<p><span style=\"font-size:12.0pt;\">Enoxaparin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is the anticoagulation of choice for a pregnant female at 36 weeks of gestation?</span></p>",
      "unique_key": "DT1325059",
      "question_audio": null,
      "question_video": null,
      "map_id": 1325059,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p><strong>Unfractionated heparin (UFH) </strong>is preferred at &ge;36 weeks gestation due to its short half-life and reversibility, making it safer around delivery.</p>\r\n<ul>\r\n<li>During pregnancy, anticoagulation must strike a balance between maternal benefit and fetal safety.</li>\r\n<li>At 36 weeks, labor can start anytime, so we need an anticoagulant that:\r\n<ul>\r\n<li>Does not cross the placenta (fetal safety)</li>\r\n<li>Can be rapidly reversed (surgical/delivery safety)</li>\r\n<li>Unfractionated Heparin (UFH) is ideal here because:</li>\r\n<li>It does not cross the placenta &rarr; safe for the fetus.</li>\r\n<li>It has a short half-life and can be reversed with protamine sulfate &rarr; ideal for sudden labor or emergency cesarean section.</li>\r\n<li>Can be stopped 4-6 hours before delivery, reducing bleeding risks.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Summary of Anticoagulant Use in Pregnancy:</strong></p><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202508282ea7e412-9520-44f7-b256-f12767c8ab5d.png\">",
      "correct_choice_id": 142,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16,
      "choices": [
        {
          "id": 151,
          "text": "<p><span style=\"font-size:12.0pt;\">Within 48 hours</span></p>"
        },
        {
          "id": 152,
          "text": "<p><span style=\"font-size:12.0pt;\">After 6 weeks</span></p>"
        },
        {
          "id": 153,
          "text": "<p><span style=\"font-size:12.0pt;\">After 3 months</span></p>"
        },
        {
          "id": 154,
          "text": "<p><span style=\"font-size:12.0pt;\">After 6 months</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A woman has just delivered a healthy baby via normal vaginal delivery. You are considering the timing of IUCD insertion for contraception. What is the earliest time at which an intrauterine contraceptive device (IUCD) can be inserted?</span></p>",
      "unique_key": "DT1325060",
      "question_audio": null,
      "question_video": null,
      "map_id": 1325060,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>An IUCD can be safely inserted within 48 hours of vaginal delivery, ideally immediately after placental expulsion, to reduce the chance of unintended pregnancy.</p>\r\n<ul>\r\n<li>Postpartum IUCD (PPIUCD) insertion is a widely recommended and effective method of long-acting reversible contraception (LARC).</li>\r\n<li>The earliest and commonly practiced insertion times are:\r\n<ul>\r\n<li>Postplacental insertion: Within 10 minutes of placental delivery, before uterine involution begins.</li>\r\n<li>Early postpartum insertion: Within 48 hours after delivery. This window is considered safe and convenient, especially if the woman is motivated for contraception and already in a healthcare setting.</li>\r\n<li>Interval IUCD: Done after 6 weeks postpartum when the uterus returns to its non-pregnant state.</li>\r\n</ul>\r\n</li>\r\n<li>Advantages of PPIUCD:\r\n<ul>\r\n<li>Convenient and acceptable (done before discharge)</li>\r\n<li>Highly effective</li>\r\n<li>Immediate protection</li>\r\n<li>No interference with breastfeeding</li>\r\n<li>Less perforation risk due to thick uterine wall</li>\r\n<li>Cost-effective</li>\r\n</ul>\r\n</li>\r\n<li>Disadvantages:\r\n<ul>\r\n<li>Higher expulsion rate than interval insertion</li>\r\n<li>Mild discomfort or bleeding</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>After 6 weeks (Option B):</strong> A common alternative, especially when missed earlier, but not the earliest time.</p>\r\n<p><strong>After 3 months (Option C):</strong> Safe, but unnecessarily delayed if immediate postpartum contraception is desired.</p>\r\n<p><strong>After 6 months (Option D):</strong> Too delayed and not standard practice unless medically indicated.</p>",
      "correct_choice_id": 151,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 17,
      "choices": [
        {
          "id": 161,
          "text": "<p><span style=\"font-size:12.0pt;\">CA125, AFP, HCG, CEA</span></p>"
        },
        {
          "id": 162,
          "text": "<p><span style=\"font-size:12.0pt;\">CA125, AFP, HCG, CA19-9</span></p>"
        },
        {
          "id": 163,
          "text": "<p><span style=\"font-size:12.0pt;\">CA125, AFP, HCG, LDH</span></p>"
        },
        {
          "id": 164,
          "text": "<p><span style=\"font-size:12.0pt;\">CA125, AFP, HCG, CA15-3</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 20-year-old female presents with an ovarian solid-cystic mass on ultrasound. Which combination of tumor markers is most appropriate for further evaluation of the likely ovarian tumor?</span></p>",
      "unique_key": "DT1325061",
      "question_audio": null,
      "question_video": null,
      "map_id": 1325061,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>These markers collectively help evaluate the most common ovarian tumors in young females, particularly germ cell tumors like yolk sac tumor, choriocarcinoma, and dysgerminoma.</p>\r\n<ul>\r\n<li>In young women (especially under 30), the most common ovarian tumors are germ cell tumors rather than epithelial ovarian cancers.</li>\r\n<li>The appropriate tumor markers help in diagnosing and monitoring specific subtypes:\r\n<ul>\r\n<li>AFP (Alpha-fetoprotein): Elevated in yolk sac tumors (endodermal sinus tumors).</li>\r\n<li>&beta;-hCG (Human chorionic gonadotropin): Elevated in choriocarcinoma and embryonal carcinoma.</li>\r\n<li>LDH (Lactate dehydrogenase): Elevated in dysgerminoma, the most common malignant germ cell tumor in this age group.</li>\r\n<li>CA-125: Typically elevated in epithelial ovarian cancer, but still assessed to rule out rare epithelial malignancy or in case of mixed pathology.</li>\r\n</ul>\r\n</li>\r\n<li>This combination is routinely ordered when evaluating ovarian masses in adolescents and young women to cover all common germ cell tumors.</li>\r\n</ul>\r\n<p><strong>Ovarian tumor classification:</strong></p><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/2025082887470e4d-40ee-415f-9769-1854e974ac04.png\">\r\n<p><strong>Ovarian Tumor Markers:</strong></p><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/2025082890e7e092-2362-4a89-a55b-9a2ea6c14a36.png\">\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>CA125, AFP, HCG, CEA (Option A):</strong> CEA is associated with gastrointestinal malignancies (e.g., colorectal cancer); not useful for evaluating ovarian germ cell tumors.</p>\r\n<p><strong>CA125, AFP, HCG, CA19-9 (Option B):</strong> CA19-9 is primarily elevated in pancreatic and gastrointestinal malignancies-not in ovarian germ cell tumors.</p>\r\n<p><strong>CA125, AFP, HCG, CA15-3 (Option D):</strong> CA15-3 is a tumor marker for breast cancer, not relevant in evaluating ovarian masses in young women.</p>",
      "correct_choice_id": 163,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18,
      "choices": [
        {
          "id": 171,
          "text": "<p><span style=\"font-size:12.0pt;\">2 days</span></p>"
        },
        {
          "id": 172,
          "text": "<p><span style=\"font-size:12.0pt;\">8 days</span></p>"
        },
        {
          "id": 173,
          "text": "<p><span style=\"font-size:12.0pt;\">14 days</span></p>"
        },
        {
          "id": 174,
          "text": "<p><span style=\"font-size:12.0pt;\">16 days</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the typical time between fertilization and implantation in human reproduction?</span></p>",
      "unique_key": "DT1325062",
      "question_audio": null,
      "question_video": null,
      "map_id": 1325062,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>Implantation usually occurs about 6-10 days post-fertilization, with the average being 8 days.</p>\r\n<ul>\r\n<li>After fertilization in the ampulla of the fallopian tube, the zygote undergoes mitotic divisions to form a morula and then a blastocyst.</li>\r\n<li>This journey takes several days as the embryo moves towards the uterus.\r\n<ul>\r\n<li>Day 3-4 post-fertilization: Morula (12-16 cell stage) enters the uterus.</li>\r\n<li>Day 4-5: Blastocyst formation begins.</li>\r\n<li>Day 6-7: Blastocyst begins attaching to the endometrial lining.</li>\r\n<li>Day 8 (average): Implantation is usually completed or actively ongoing.</li>\r\n</ul>\r\n</li>\r\n<li>Thus, 8 days is considered the average time for implantation to begin.</li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>2 days (Option A):</strong> Too early for implantation; the zygote is still in the fallopian tube undergoing cleavage.</p>\r\n<p><strong>14 days (Option C):</strong> Implantation should already be completed by this time; by now, hCG levels may be detectable in blood.</p>\r\n<p><strong>16 days (Option D):</strong> Implantation beyond this point is unlikely; if not implanted by now, the embryo is typically non-viable.</p>",
      "correct_choice_id": 172,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19,
      "choices": [
        {
          "id": 181,
          "text": "<p><span style=\"font-size:12.0pt;\">Placenta previa</span></p>"
        },
        {
          "id": 182,
          "text": "<p><span style=\"font-size:12.0pt;\">Twin pregnancy</span></p>"
        },
        {
          "id": 183,
          "text": "<p><span style=\"font-size:12.0pt;\">Primigravida</span></p>"
        },
        {
          "id": 184,
          "text": "<p><span style=\"font-size:12.0pt;\">PROM (Premature Rupture of Membranes)</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 37-week pregnant woman with a breech presentation is being evaluated for external cephalic version (ECV). Which of the following is not a contraindication for ECV?</span></p>",
      "unique_key": "DT1325063",
      "question_audio": null,
      "question_video": null,
      "map_id": 1325063,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>Primigravida is not a contraindication for ECV; the procedure can be safely attempted in first-time mothers under appropriate clinical settings.</p>\r\n<ul>\r\n<li>External Cephalic Version (ECV) is a procedure used to turn a fetus from breech to cephalic presentation by manual manipulation through the maternal abdomen.</li>\r\n<li>It is generally attempted around 37 weeks of gestation when the baby is mature, but before labor begins.</li>\r\n<li>Prerequisites for ECV:\r\n<ul>\r\n<li>Singleton pregnancy</li>\r\n<li>Adequate amniotic fluid</li>\r\n<li>Intact membranes</li>\r\n<li>Reactive NST (Non-stress test)</li>\r\n<li>No contraindications to vaginal delivery</li>\r\n</ul>\r\n</li>\r\n<li>Contraindications for ECV include:\r\n<ul>\r\n<li>Absolute:\r\n<ul>\r\n<li>Placenta previa (risk of hemorrhage)</li>\r\n<li>Previous classical cesarean scar or uterine rupture risk</li>\r\n<li>Multiple pregnancy (e.g., twins)</li>\r\n</ul>\r\n</li>\r\n<li>Relative:\r\n<ul>\r\n<li>PROM (risk of infection and cord prolapse)</li>\r\n<li>Oligohydramnios</li>\r\n<li>Fetal compromise</li>\r\n<li>Uterine anomalies</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n</li>\r\n<li>Being a primigravida is not a contraindication.</li>\r\n<li>While multiparous women generally have higher success rates, ECV is routinely and safely attempted in primigravidas as well.</li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>Placenta previa (Option A):</strong> Absolute contraindication due to risk of bleeding when manipulating the uterus.</p>\r\n<p><strong>Twin pregnancy (Option B):</strong> Contraindicated as manual rotation of one fetus may affect the position of the second, increasing risk.</p>\r\n<p><strong>PROM (Option D):</strong> Contraindicated due to risks of cord prolapse, infection, and reduced amniotic fluid, which hinders manipulation.</p>",
      "correct_choice_id": 183,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20,
      "choices": [
        {
          "id": 191,
          "text": "<p><span style=\"font-size:12.0pt;\">Ampulla - As it has a uniform thickness of muscle</span></p>"
        },
        {
          "id": 192,
          "text": "<p><span style=\"font-size:12.0pt;\">Ampulla - As it is the widest part</span></p>"
        },
        {
          "id": 193,
          "text": "<p><span style=\"font-size:12.0pt;\">Ampulla-Isthmus junction - As it is the site of fertilization</span></p>"
        },
        {
          "id": 194,
          "text": "<p><span style=\"font-size:12.0pt;\">Isthmus - As it is the narrowest part</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A woman is undergoing elective tubal ligation for permanent contraception. Which is the most common site selected for ligation, and what is the reason for choosing this site?</span></p>",
      "unique_key": "DT1325064",
      "question_audio": null,
      "question_video": null,
      "map_id": 1325064,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation of answer:</strong></p>\r\n<p>The isthmus is chosen for tubal ligation because its narrow diameter ensures effective blockage and lower failure rates.</p>\r\n<ul>\r\n<li>The isthmus is the narrow, straight portion of the fallopian tube located closest to the uterus.</li>\r\n<li>It is the most common and preferred site for tubal ligation (tubectomy) because:\r\n<ul>\r\n<li>It is easy to access surgically.</li>\r\n<li>Its narrow lumen allows more secure occlusion, reducing the chance of recanalization or tubal failure.</li>\r\n<li>There is less vascularity in this region, which decreases intraoperative bleeding risks.</li>\r\n</ul>\r\n</li>\r\n<li>Tubal ligation procedures such as Pomeroy's, Parkland, or Irving methods are typically done at the isthmic segment.</li>\r\n<li>Sterilization effectiveness is highest when this site is targeted.</li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>Ampulla - As it has a uniform thickness of muscle (Option A):</strong> While the ampulla has a uniform muscle layer, this is not relevant for sterilization. The site's width makes it less suitable for effective occlusion.</p>\r\n<p><strong>Ampulla - As it is the widest part (Option B):</strong> Its wide diameter actually increases the risk of failure, as blocking a wider tube is less secure.</p>\r\n<p><strong>Ampulla-Isthmus junction - As it is the site of fertilization (Option C):</strong> Although fertilization typically occurs here, ligation at this site is not preferred due to anatomical variability and higher technical difficulty.</p>",
      "correct_choice_id": 194,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 21,
      "choices": [
        {
          "id": 201,
          "text": "<p><span style=\"font-size:12.0pt;\">Propylthiouracil (PTU)</span></p>"
        },
        {
          "id": 202,
          "text": "<p><span style=\"font-size:12.0pt;\">Methimazole</span></p>"
        },
        {
          "id": 203,
          "text": "<p><span style=\"font-size:12.0pt;\">Carbimazole</span></p>"
        },
        {
          "id": 204,
          "text": "<p><span style=\"font-size:12.0pt;\">Propranolol</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A pregnant woman at 8 weeks of gestation presents with symptoms suggestive of hyperthyroidism. What is the drug of choice for treating hyperthyroidism during the first trimester of pregnancy?</span></p>",
      "unique_key": "DT1325065",
      "question_audio": null,
      "question_video": null,
      "map_id": 1325065,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p><strong>PTU</strong> is preferred in the first trimester as it carries less teratogenic risk compared to <strong>methimazole and carbimazole.</strong></p>\r\n<ul>\r\n<li>In pregnancy, managing maternal hyperthyroidism requires balancing maternal health and fetal safety.</li>\r\n<li>During the first trimester (up to 12 weeks):\r\n<ul>\r\n<li>PTU is preferred because:\r\n<ul>\r\n<li>It is less teratogenic than methimazole/carbimazole.</li>\r\n<li>It reduces the risk of congenital anomalies during organogenesis.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n</li>\r\n<li>After the first trimester, the drug is usually switched to methimazole to avoid the risk of hepatotoxicity associated with long-term PTU use.</li>\r\n<li>Teratogenic risks of Methimazole and Carbimazole (when used in 1st trimester):\r\n<ul>\r\n<li>Aplasia cutis congenita (absence of skin, often on the scalp)</li>\r\n<li>Choanal atresia</li>\r\n<li>Tracheoesophageal fistula</li>\r\n<li>Fetal goiter or hypothyroidism</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Clinical Approach to Hyperthyroidism in Pregnancy:</strong></p><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250828549af0ab-ebd7-4249-892b-4a26d7fea6e2.png\">\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>Methimazole (Option B):</strong> Associated with teratogenic effects in the 1st trimester. It is used after the 1st trimester once organogenesis is complete.</p>\r\n<p><strong>Carbimazole (Option C):</strong> A prodrug of methimazole with the same teratogenic risks. Not preferred in early pregnancy.</p>\r\n<p><strong>Propranolol (Option D):</strong> A beta-blocker used only for symptomatic relief (tachycardia, tremors) but not a definitive treatment for hyperthyroidism. It may be added temporarily but is not the drug of choice.</p>",
      "correct_choice_id": 201,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 22,
      "choices": [
        {
          "id": 211,
          "text": "<p><span style=\"font-size:12.0pt;\">Respiratory rate (RR) < 18 breaths per minute</span></p>"
        },
        {
          "id": 212,
          "text": "<p><span style=\"font-size:12.0pt;\">Visual disturbances start</span></p>"
        },
        {
          "id": 213,
          "text": "<p><span style=\"font-size:12.0pt;\">Knee jerk reflex is present</span></p>"
        },
        {
          "id": 214,
          "text": "<p><span style=\"font-size:12.0pt;\">Urine output of less than 60 ml in 4 hours</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A woman at 32 weeks of gestation presents with a heart rate of 120 bpm and blood pressure of 160/110 mmHg. She has pedal edema and proteinuria and is diagnosed with eclampsia. She is started on the Pritchard regimen with magnesium sulfate. Under which of the following conditions should the treatment be stopped?</span></p>",
      "unique_key": "DT1325066",
      "question_audio": null,
      "question_video": null,
      "map_id": 1325066,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>Urine output less than 30 ml/hour (i.e., &lt;60 ml in 4 hours) indicates possible magnesium accumulation and impending toxicity, necessitating cessation of magnesium sulfate.</p>\r\n<ul>\r\n<li>Magnesium sulfate is the first-line drug for seizure prophylaxis in eclampsia.</li>\r\n<li>The Pritchard regimen involves a loading dose of 4 g IV and 10 g IM (5 g in each buttock), followed by a maintenance dose of 5 g IM every 4 hours in alternate buttocks.</li>\r\n<li>Before giving each dose, three parameters must be confirmed:\r\n<ul>\r\n<li>Respiratory rate &ge; 16/min</li>\r\n<li>Patellar reflexes present</li>\r\n<li>Urine output &ge; 30 ml/hr</li>\r\n</ul>\r\n</li>\r\n<li>If urine output is &lt;60 ml in 4 hours, magnesium excretion is reduced, increasing the risk of toxicity (due to renal clearance dependency).</li>\r\n<li>In such cases, withholding the next dose and close monitoring is essential.</li>\r\n<li>If signs of toxicity appear (respiratory depression, areflexia), 10 ml of 10% calcium gluconate IV is the antidote.</li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>Respiratory rate (RR) &lt; 18 breaths per minute (Option A):</strong> While a low RR (&lt;12/min) is a classic sign of toxicity, 18/min is not a cutoff to stop the drug. A RR &lt;16/min should raise concern, but &lt;12/min mandates immediate discontinuation and treatment.</p>\r\n<p><strong>Visual disturbances start (Option B):</strong> This is a feature of worsening preeclampsia or impending eclampsia, not magnesium toxicity. It is not an indication to stop magnesium sulfate.</p>\r\n<p><strong>Knee jerk reflex is present (Option C):</strong> Presence of patellar reflex is reassuring and required before giving each dose. Loss of reflex would indicate magnesium toxicity and is a contraindication to further dosing.</p>\r\n<p><strong>Reference:</strong></p>\r\n<p><a href=\"https://www.bioline.org.br/pdf?am09018\">https://www.bioline.org.br/pdf?am09018</a> page 78</p>",
      "correct_choice_id": 214,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 23,
      "choices": [
        {
          "id": 221,
          "text": "<p><span style=\"font-size:12.0pt;\">Endometriosis</span></p>"
        },
        {
          "id": 222,
          "text": "<p><span style=\"font-size:12.0pt;\">Melanoma</span></p>"
        },
        {
          "id": 223,
          "text": "<p><span style=\"font-size:12.0pt;\">Foreign body granuloma</span></p>"
        },
        {
          "id": 224,
          "text": "<p><span style=\"font-size:12.0pt;\">Inclusion cyst</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient presents with a new 2 cm black nodular mass near an episiotomy scar that is painful and expands during menstruation. What is the most likely cause?</span></p>",
      "unique_key": "DT1325067",
      "question_audio": null,
      "question_video": null,
      "map_id": 1325067,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>Endometriosis involving a scar site presents as a painful nodular mass that enlarges cyclically with menstruation.</p>\r\n<ul>\r\n<li>Endometriosis is defined as the presence of functional endometrial glands and stroma outside the uterine cavity.</li>\r\n<li>When endometrial tissue implants in surgical scars-such as an episiotomy site-it can lead to scar endometriosis.</li>\r\n<li>These lesions respond to hormonal changes, causing cyclical pain and swelling during menstruation.</li>\r\n<li>On examination, they often appear as firm, pigmented nodules and may mimic other pathologies like tumors or granulomas.</li>\r\n<li>Scar endometriosis should be suspected in any reproductive-aged woman with a history of obstetric or gynecologic surgery who presents with localized pain and a mass that fluctuates with her cycle.</li>\r\n</ul>\r\n<p><strong>Various sites where endometriosis can occur:</strong></p><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250828504a7a0d-21eb-4cb9-92f9-21544cafb427.png\">\r\n<ul>\r\n<li><strong>Diagnosis Guidelines:</strong>\r\n<ul>\r\n<li>Current guidelines do not require histologic confirmation to diagnose endometriosis, often based on clinical presentation and macroscopic findings during laparoscopy.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Macroscopic Findings:</strong>\r\n<ul>\r\n<li><strong>Powder-burn or Gunshot Lesions: </strong>Dark, blackish-bluish puckered lesions on the peritoneal surface.</li>\r\n<li><strong>Clear Vesicles:</strong> Small, blister-like lesions on the ovarian surface or peritoneum.</li>\r\n<li><strong>Red Polypoidal Lesions:</strong> Red, polyp-like, vascularised lesions.</li>\r\n<li><strong>White Scarred Lesions:</strong> White, scar-like areas with fibrosis and few blood vessels.</li>\r\n<li><strong>Yellow-brown Peritoneal Discoloration:</strong> Indicates hemosiderin deposition and chronic endometriosis.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Correlation of Gross Appearance with Microscopic Findings</strong>\r\n<ul>\r\n<li><strong>Red Lesions:</strong> Vascularized, indicating active endometriotic tissue.</li>\r\n<li><strong>White Lesions:</strong> Fibrosis with few vessels, suggesting chronic or scarred tissue.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Histologic Examination</strong>\r\n<ul>\r\n<li><strong>Hemosiderin Deposition: </strong>Common in histologic samples, indicating prior bleeding within the lesion.</li>\r\n<li><strong>Histologic Diagnosis Criteria:</strong> The presence of both endometrial glands and stroma is required to confirm endometriosis.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>Melanoma (Option B):</strong> A pigmented, possibly nodular skin cancer, but it does not fluctuate with the menstrual cycle and is typically painless in early stages.</p>\r\n<p><strong>Foreign body granuloma (Option C):</strong> Results from retained suture or tissue, forming a firm, non-pigmented lump; typically non-cyclic and non-menstruation-related.</p>\r\n<p><strong>Inclusion cyst (Option D):</strong> A painless, smooth, epithelial-lined cyst resulting from trauma or surgery; does not enlarge or become painful during menstruation.</p>",
      "correct_choice_id": 221,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24,
      "choices": [
        {
          "id": 231,
          "text": "<p><span style=\"font-size:12.0pt;\">Gynaecologist</span></p>"
        },
        {
          "id": 232,
          "text": "<p><span style=\"font-size:12.0pt;\">Radiologist</span></p>"
        },
        {
          "id": 233,
          "text": "<p><span style=\"font-size:12.0pt;\">Pediatrician</span></p>"
        },
        {
          "id": 234,
          "text": "<p><span style=\"font-size:12.0pt;\">Lawyer</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A woman seeks Medical Termination of Pregnancy (MTP) after 24 weeks of gestation due to fetal anomalies. Whose opinion is not required in this decision?</span></p>",
      "unique_key": "DT1325080",
      "question_audio": null,
      "question_video": null,
      "map_id": 1325080,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>The opinion of a lawyer is not required for MTP beyond 24 weeks; only a medical board consisting of a gynecologist, radiologist, and pediatrician is mandated by the <strong>MTP Act</strong>.</p>\r\n<ul>\r\n<li>Under the <strong>MTP (Amendment) Act, 2021</strong>, MTP beyond 24 weeks is legally permitted only in cases of substantial fetal anomalies.</li>\r\n<li>This requires the opinion of a state-level medical board, constituted as follows:\r\n<ul>\r\n<li>Gynaecologist: Evaluates maternal health and carries out or advises on termination.</li>\r\n<li>Radiologist: Confirms fetal anomalies through imaging (ultrasound, MRI).</li>\r\n<li>Pediatrician: Assesses postnatal prognosis and viability of the fetus.</li>\r\n</ul>\r\n</li>\r\n<li>The lawyer is not a member of this medical board. While legal proceedings may occasionally be involved, legal counsel is not needed for medical decision-making or approval under the act.</li>\r\n</ul>\r\n<p><strong>Medical Termination of Pregnancy (MTP) Act:</strong></p>\r\n<ul>\r\n<li>The original act was passed in 1971 and amended in 2021.</li>\r\n<li><strong>Indications</strong>:\r\n<ul>\r\n<li>Maternal Risk</li>\r\n<li>Fetal Risk: Spina bifida, Down syndrome.</li>\r\n<li>Eugenic Conditions: Risks to both mother and fetus.</li>\r\n<li>Humanitarian Cause: Pregnancy resulting from rape.</li>\r\n<li>Contraceptive Failure.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Qualifications</strong>:\r\n<ul>\r\n<li>MBBS, MD/DNB/DGO</li>\r\n<li>MBBS who has trained in gynaecology for 6 months</li>\r\n<li>MBBS who has performed 25 MTPs under supervision</li>\r\n<li>ASHA and AYUSH cannot perform MTP.</li>\r\n</ul>\r\n</li>\r\n<li><strong><strong>Additions of 2021 amendment:</strong></strong>\r\n<ul>\r\n<li>Abortions allowed up to 20-24 weeks.</li>\r\n<li>&lt;20 weeks - Single doctor&rsquo;s decision; 20-24 weeks - 2 doctors.</li>\r\n<li>Extension of abortion rights to single, unmarried females.</li>\r\n<li>Inclusion of marital rape under the MTP Act.</li>\r\n<li>Abortions &gt;24 weeks in cases of significant fetal anomalies with no gestational upper limit, are to be decided by a state medical board<strong>(gynecologist, pediatrician, radiologist). (Options A,B,C ruled out)</strong></li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Reference:</strong></p>\r\n<p><a href=\"https://nhm.hp.gov.in/storage/app/media/uploaded-files/mtp-amendment-act2021.pdf\">https://nhm.hp.gov.in/storage/app/media/uploaded-files/mtp-amendment-act2021.pdf</a> page 2</p>",
      "correct_choice_id": 234,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 25,
      "choices": [
        {
          "id": 241,
          "text": "<p><span style=\"font-size:12.0pt;\">Intramural fibroid</span></p>"
        },
        {
          "id": 242,
          "text": "<p><span style=\"font-size:12.0pt;\">Adenomyoma</span></p>"
        },
        {
          "id": 243,
          "text": "<p><span style=\"font-size:12.0pt;\">Endometrioma</span></p>"
        },
        {
          "id": 244,
          "text": "<p><span style=\"font-size:12.0pt;\">Myomatous polyp</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 35-year-old woman presents with chronic lower abdominal pain that worsens during menstruation. An ultrasound (USG) shows a cystic ovarian mass with a \"ground glass\" appearance. Which of the following conditions is most likely associated with these findings?</span></p>",
      "unique_key": "DT1325116",
      "question_audio": null,
      "question_video": null,
      "map_id": 1325116,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation of answer:</strong></p>\r\n<p>Endometriomas are cystic ovarian lesions associated with endometriosis and show a characteristic \"ground glass\" appearance on ultrasound.</p>\r\n<ul>\r\n<li>Endometriosis is a chronic gynecological condition where ectopic endometrial tissue is found outside the uterus, commonly on ovaries.</li>\r\n<li>When endometriosis involves the ovaries, it leads to the formation of endometriomas-also called \"chocolate cysts\" due to the presence of altered blood.</li>\r\n<li>Ultrasound (USG) findings show a cystic mass with homogeneous low-level internal echoes, termed a \"ground glass\" appearance.<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250829eaea82ee-38d6-4142-b97b-ab06b4b7dfdb.png\"></li>\r\n<li>This is typical of endometriomas and helps distinguish them from other adnexal masses.</li>\r\n<li>Associated diagnostic points:\r\n<ul>\r\n<li>Laparoscopy is the investigation of choice.</li>\r\n<li>Histopathology confirms the diagnosis, showing hemosiderin-laden macrophages.</li>\r\n<li>MRI helps with better characterisation, showing hyperintense T1 and \"shading\" on T2.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>Intramural fibroid (Option A):</strong> Solid masses within the uterine wall; do not appear cystic or have ground glass appearance.</p>\r\n<p><strong>Adenomyoma (Option B):</strong> Appears as a heterogeneous mass in the myometrium, not as a cystic ovarian lesion.</p>\r\n<p><strong>Myomatous polyp (Option D):</strong> Pedunculated, solid uterine masses; not associated with ovarian cysts or ground glass appearance.</p>\r\n<p><strong>Reference:</strong><a href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10120420/\">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10120420/</a></p>",
      "correct_choice_id": 243,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 26,
      "choices": [
        {
          "id": 251,
          "text": "<p><span style=\"font-size:12.0pt;\">LBC, HPV antigen testing, Cervical biopsy</span></p>"
        },
        {
          "id": 252,
          "text": "<p><span style=\"font-size:12.0pt;\">Pap smear, HSV testing, Cervical biopsy</span></p>"
        },
        {
          "id": 253,
          "text": "<p><span style=\"font-size:12.0pt;\">Pap smear, HBV DNA, Cervical biopsy</span></p>"
        },
        {
          "id": 254,
          "text": "<p><span style=\"font-size:12.0pt;\">LBC, HSV testing only</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 45-year-old woman presents with complaints of spotting and foul-smelling discharge for the past 2 months. On examination, cervical erosions are seen.</span></p>",
      "unique_key": "DT1325117",
      "question_audio": null,
      "question_video": null,
      "map_id": 1325117,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>LBC with HPV testing and cervical biopsy offers the most comprehensive evaluation for cervical dysplasia and malignancy.</p>\r\n<ul>\r\n<li>In a woman presenting with abnormal vaginal discharge, intermenstrual spotting, and visible cervical erosion, the clinical concern includes cervical intraepithelial neoplasia (CIN) or early cervical carcinoma, particularly in the context of persistent infection by high-risk HPV types.</li>\r\n<li>Hence, a triple assessment is warranted:\r\n<ul>\r\n<li>LBC (Liquid-Based Cytology): Modern alternative to conventional Pap smear, with better cell preservation and less debris.Useful for identifying cytological abnormalities like koilocytes, dyskaryosis, and CIN.</li>\r\n<li>HPV antigen testing: Essential for detecting high-risk HPV strains (especially 16, 18), which are implicated in &gt;95% of cervical cancers.</li>\r\n<li>Cervical biopsy: Provides a histopathological diagnosis to confirm dysplasia or malignancy, especially when there are suspicious cervical lesions or persistent symptoms.</li>\r\n</ul>\r\n</li>\r\n<li>This combination maximizes diagnostic sensitivity and guides further management (colposcopy, LEEP, etc.).</li>\r\n</ul><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250829f13d0000-4725-42af-bddc-f030444b8b25.png\">\r\n<p><strong>Koilocytes </strong></p>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>Pap smear, HSV testing, Cervical biopsy (Option B):</strong> HSV testing is not warranted here as there's no vesicular lesion or ulcerative complaint suggestive of herpes. Pap smear is acceptable, but LBC is superior.</p>\r\n<p><strong>Pap smear, HBV DNA, Cervical biopsy (Option C):</strong> HBV DNA is unrelated to cervical complaints; it is relevant in liver disease, not gynecological evaluation.</p>\r\n<p><strong>LBC, HSV testing only (Option D):</strong> Missing HPV testing and biopsy-two essential components in evaluating pre-malignant/malignant cervical lesions.</p>\r\n<p><strong>Reference: </strong><a href=\"https://www.nature.com/articles/6605328\">https://www.nature.com/articles/6605328</a></p>",
      "correct_choice_id": 251,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 27,
      "choices": [
        {
          "id": 261,
          "text": "<p><span style=\"font-size:12.0pt;\">Leave IUCD inside and continue pregnancy with prophylactic antibiotics</span></p>"
        },
        {
          "id": 262,
          "text": "<p><span style=\"font-size:12.0pt;\">Leave IUCD inside and continue pregnancy</span></p>"
        },
        {
          "id": 263,
          "text": "<p><span style=\"font-size:12.0pt;\">Remove IUCD immediately and continue with pregnancy</span></p>"
        },
        {
          "id": 264,
          "text": "<p><span style=\"font-size:12.0pt;\">Termination of pregnancy due to risk of infection</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 28-year-old woman with a 10-week intrauterine gestation presents to the OPD with an intrauterine contraceptive device (IUCD) in place. The IUCD thread is clearly visible. She expresses her desire to continue the pregnancy. What is the next best step in management?</span></p>",
      "unique_key": "DT1325118",
      "question_audio": null,
      "question_video": null,
      "map_id": 1325118,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>If the IUCD thread is visible and the woman wishes to continue the pregnancy, the IUCD should be removed immediately to reduce the risk of miscarriage and infection.</p>\r\n<ul>\r\n<li>Pregnancy with an IUCD in situ carries significant risks including miscarriage, intrauterine infection, preterm labor, and intrauterine growth restriction.</li>\r\n<li>When the IUCD thread is visible and easily accessible, removal during the first trimester is the recommended management.</li>\r\n<li>This significantly improves pregnancy outcomes and reduces complications compared to leaving the IUCD in place.</li>\r\n<li>Removal should be performed carefully to avoid disruption of the gestational sac.</li>\r\n<li>If the IUCD cannot be safely removed (e.g., no visible thread or device embedded), options depend on IUCD position and patient preference.</li>\r\n<li>If removal isn't feasible and the patient still wishes to continue the pregnancy, close monitoring is required.</li>\r\n<li>Management algorithm:\r\n<ul>\r\n<li>Thread visible: Remove IUCD immediately.</li>\r\n<li>Thread not visible, IUCD not fundal: Attempt ultrasound-guided removal or offer termination.</li>\r\n<li>Thread not visible, IUCD in fundus: May consider continuation with IUCD in place under close surveillance.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>Leave IUCD inside and continue pregnancy with prophylactic antibiotics (Option A):</strong> Not routinely recommended. Antibiotics don't eliminate the risks of septic abortion, miscarriage, or preterm labor. Removal is preferred when the thread is visible.</p>\r\n<p><strong>Leave IUCD inside and continue pregnancy (Option B):</strong> Increases risks of adverse pregnancy outcomes. Since thread is visible, removal is feasible and thus preferred.</p>\r\n<p><strong>Termination of pregnancy due to risk of infection (Option D):</strong> Termination is not indicated if the patient wants to continue and the IUCD can be safely removed. It may be considered if IUCD cannot be removed or the patient opts for termination.</p>",
      "correct_choice_id": 263,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 28,
      "choices": [
        {
          "id": 271,
          "text": "<p><span style=\"font-size:12.0pt;\">Bicornuate uterus</span></p>"
        },
        {
          "id": 272,
          "text": "<p><span style=\"font-size:12.0pt;\">Didelphys uterus</span></p>"
        },
        {
          "id": 273,
          "text": "<p><span style=\"font-size:12.0pt;\">Arcuate uterus</span></p>"
        },
        {
          "id": 274,
          "text": "<p><span style=\"font-size:12.0pt;\">Septate uterus</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Identify the type of uterus shown in the image.<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250829221a167b-e938-42c3-9533-f78cebccd4c7.png\"></span></p>",
      "unique_key": "DT1325119",
      "question_audio": null,
      "question_video": null,
      "map_id": 1325119,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>Didelphys uterus results from complete failure of M&uuml;llerian duct fusion, leading to two separate uterine cavities with individual endometrial linings and often two crevices.</p>\r\n<ul>\r\n<li>A didelphys uterus arises due to complete non-fusion of the paired M&uuml;llerian ducts during embryogenesis.</li>\r\n<li>It results in two entirely separate uterine horns, often with two separate endometrial cavities and two cervices, and occasionally a longitudinal vaginal septum as well.</li>\r\n<li>This anomaly is best seen on imaging such as MRI or HSG, which shows two symmetric, widely spaced endometrial canals with no communication.</li>\r\n<li>These findings, along with the presence of two distinct cervical canals, confirm the diagnosis.</li>\r\n<li>Women with a didelphys uterus have an increased risk of miscarriage, preterm labor, and abnormal fetal presentations.</li>\r\n<li>However, some can carry pregnancies to term.</li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>Bicornuate uterus (Option A):</strong> Incomplete fusion of the M&uuml;llerian ducts results in a uterus with two horns and a single cervix. The endometrial canals are partially joined and separated at the top with an external fundal indentation &gt;10 mm and intercornual angle &gt;105&deg;.</p>\r\n<p><strong>Arcuate uterus (Option C)</strong>: A normal variant with a mild concave indentation of the uterine fundus. The intercornual angle is &gt;105&deg;, and the depth of indentation is &lt;10 mm, not associated with adverse pregnancy outcomes.</p>\r\n<p><strong>Septate uterus (Option D):</strong> Caused by failure of resorption of the uterine septum. On imaging, the uterine fundus is normal (convex/flat), but the cavity is divided by a fibrous or muscular septum with an intercornual angle &lt;75&deg; and a fundal indentation depth &gt;10 mm.</p><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/2025082997b7a99e-a658-4279-8d33-4d0ae23b4644.png\">\r\n<p><strong>Hysterosalpingogram showing acute angle in a septate uterus (A) and wider angle in a bicornuate uterus (B).</strong></p>",
      "correct_choice_id": 272,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 29,
      "choices": [
        {
          "id": 281,
          "text": "<p><span style=\"font-size:12.0pt;\">1st degree</span></p>"
        },
        {
          "id": 282,
          "text": "<p><span style=\"font-size:12.0pt;\">2nd degree</span></p>"
        },
        {
          "id": 283,
          "text": "<p><span style=\"font-size:12.0pt;\">3rd degree</span></p>"
        },
        {
          "id": 284,
          "text": "<p><span style=\"font-size:12.0pt;\">3rd degree</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A primigravida experienced precipitous labor while arriving at the hospital. When she reached the hospital, the injury was observed on her perineum, an image of which is given below. Identify the degree of perineal tear in the image shown below.<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202508298f4406d0-5440-4ff2-b7b9-38d97fad1c75.png\"></span></p>",
      "unique_key": "DT1325120",
      "question_audio": null,
      "question_video": null,
      "map_id": 1325120,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>3rd-degree perineal tears extend to the anal sphincter but do not involve the rectal mucosa.</p>\r\n<ul>\r\n<li>A third-degree perineal tear involves disruption of the vaginal mucosa, perineal skin, perineal muscles, and extends to the anal sphincter complex, specifically the external anal sphincter (EAS) and possibly the internal anal sphincter (IAS).</li>\r\n<li>However, the rectal mucosa is not breached, which distinguishes it from a fourth-degree tear.</li>\r\n<li>Subtypes of 3rd-degree tears include:\r\n<ul>\r\n<li>3a: &lt;50% of EAS torn</li>\r\n<li>3b: &gt;50% of EAS torn</li>\r\n<li>3c: Both EAS and IAS are torn</li>\r\n</ul>\r\n</li>\r\n<li>These tears often result from precipitous labor, instrumental deliveries (e.g., forceps), macrosomia, or narrow pelvic outlet.</li>\r\n<li>Prompt surgical repair is necessary to prevent complications like fecal incontinence.</li>\r\n</ul>\r\n<p><strong>Risk factors of perineal tear: </strong></p>\r\n<ul>\r\n<li>Big baby(weight &ge; 3 kg).</li>\r\n<li>Nulliparity</li>\r\n<li>Outlet contraction with narrow pubic arch.</li>\r\n<li>Shoulder dystocia.</li>\r\n<li>Forceps delivery.</li>\r\n<li>Scar in the perineum (perineorrhaphy, episiotomy).</li>\r\n<li>Face to pubis delivery.</li>\r\n<li>Midline episiotomy.</li>\r\n<li>Precipitate labour.<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250829f2436542-6ea4-416a-a410-378ea0d9d717.png\"></li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>1st degree (Option A):</strong> Involves only the vaginal epithelium and perineal skin without extension into muscle or sphincter.</p>\r\n<p><strong>2nd degree (Option B):</strong> Involves vaginal mucosa, perineal skin, and perineal muscles, but not the anal sphincter.</p>\r\n<p><strong>4th degree (Option D):</strong> Extends through the vaginal mucosa, perineal muscles, both anal sphincters, and into the rectal mucosa, making it the most severe.</p>",
      "correct_choice_id": 283,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 30,
      "choices": [
        {
          "id": 291,
          "text": "<p><span style=\"font-size:12.0pt;\">Simpson</span></p>"
        },
        {
          "id": 292,
          "text": "<p><span style=\"font-size:12.0pt;\">Wrigley</span></p>"
        },
        {
          "id": 293,
          "text": "<p><span style=\"font-size:12.0pt;\">Piper</span></p>"
        },
        {
          "id": 294,
          "text": "<p><span style=\"font-size:12.0pt;\">Kielland</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Identify the instrument shown below.<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/2025082976e18b7c-7532-440f-923c-fbb2ff303fea.png\"></span></p>",
      "unique_key": "DT1325121",
      "question_audio": null,
      "question_video": null,
      "map_id": 1325121,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>Piper forceps are uniquely designed with a perineal curve for delivering the after-coming head in breech presentations.</p>\r\n<ul>\r\n<li>Piper forceps are specialized obstetric forceps used exclusively for breech deliveries to aid in delivering the after-coming head.</li>\r\n<li>Their design includes asymmetrical blades (one solid and one fenestrated), a reverse pelvic curve, and long shanks, allowing the forceps to be applied around the fetal head while keeping the fetal body lifted.</li>\r\n<li>This minimizes the risk of cervical spine injury, a major concern in breech deliveries.</li>\r\n<li>The unique curvature allows perineal application without disturbing the fetal body.</li>\r\n<li>These forceps are applied under the fetal body, which is held up by an assistant, allowing the blades to be positioned properly on the fetal head.</li>\r\n<li>Once locked, gentle traction is applied to deliver the head safely.</li>\r\n</ul>\r\n<p><strong>Instruments and uses:</strong></p><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250829c79265df-3e7a-4b2a-b50c-3a0003c25edb.png\">",
      "correct_choice_id": 293,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 31,
      "choices": [
        {
          "id": 301,
          "text": "<p><span style=\"font-size:12.0pt;\">Hydrosalpinx</span></p>"
        },
        {
          "id": 302,
          "text": "<p><span style=\"font-size:12.0pt;\">Follicular ovarian cyst</span></p>"
        },
        {
          "id": 303,
          "text": "<p><span style=\"font-size:12.0pt;\">Endometriosis</span></p>"
        },
        {
          "id": 304,
          "text": "<p><span style=\"font-size:12.0pt;\">Hemorrhagic ovarian cyst</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 29-year-old woman presents with a history of infertility and chronic pelvic pain. A transvaginal ultrasound is performed, which reveals an adnexal mass characterized by incomplete septations and a cogwheel appearance. What is the most likely diagnosis?</span></p>",
      "unique_key": "DT1325122",
      "question_audio": null,
      "question_video": null,
      "map_id": 1325122,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>A cogwheel appearance with incomplete septations on ultrasound is most characteristic of hydrosalpinx, especially in chronic cases with inflammation.</p>\r\n<ul>\r\n<li>Hydrosalpinx refers to the accumulation of serous fluid within a fallopian tube due to distal tubal obstruction.</li>\r\n<li>This chronic condition often results from pelvic inflammatory disease, endometriosis, or tubercular salpingitis.</li>\r\n<li>Over time, the inflamed and damaged tubal epithelium leads to loss of fimbrial architecture, forming a smooth, clubbed end filled with fluid.</li>\r\n<li>On transvaginal ultrasound, the hallmark features include:\r\n<ul>\r\n<li>A thin-walled, cystic tubular or fusiform structure.</li>\r\n<li>Incomplete septations due to residual endosalpingeal folds.</li>\r\n<li>Cogwheel or beads-on-a-string appearance, particularly in chronic inflammation, reflecting thickened longitudinal mucosal folds.</li>\r\n</ul>\r\n</li>\r\n<li>These sonographic findings are highly suggestive of hydrosalpinx, especially in the context of infertility or pelvic pain.</li>\r\n<li>Hydrosalpinx impacts fertility and may significantly reduce IVF success rates by 50% due to toxic fluid and embryo washout.</li>\r\n<li>Surgical resection before IVF improves outcomes.</li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>Follicular ovarian cyst (Option B):</strong> These are simple, thin-walled, anechoic cysts formed from unruptured follicles. They do not exhibit incomplete septations or cogwheel appearance.</p>\r\n<p><strong>Endometriosis (Option C):</strong> Endometriomas typically show homogeneous, \"ground-glass\" internal echoes. They are not associated with incomplete septations or cogwheel patterns.</p>\r\n<p><strong>Hemorrhagic ovarian cyst (Option D):</strong> These may show internal echoes or fibrin strands but the cogwheel sign is not typical. Although septations may appear due to clots, the structure is usually not tubular or fusiform as in hydrosalpinx.</p>",
      "correct_choice_id": 301,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 32,
      "choices": [
        {
          "id": 311,
          "text": "<p><span style=\"font-size:12.0pt;\">LSCS, vaginal</span></p>"
        },
        {
          "id": 312,
          "text": "<p><span style=\"font-size:12.0pt;\">Vaginal, LSCS</span></p>"
        },
        {
          "id": 313,
          "text": "<p><span style=\"font-size:12.0pt;\">Normal vaginal delivery for both</span></p>"
        },
        {
          "id": 314,
          "text": "<p><span style=\"font-size:12.0pt;\">LSCS for both</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the preferred method of delivery for twin A and twin B of the twin pregnancy, as shown in the image below?<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250829bc19636f-1239-4cd9-9a7f-51fe523fb451.png\"></span></p>",
      "unique_key": "DT1325123",
      "question_audio": null,
      "question_video": null,
      "map_id": 1325123,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>When both twins are in cephalic presentation, normal vaginal delivery is the preferred mode unless there are other contraindications.</p>\r\n<ul>\r\n<li>In twin pregnancies, the presentation of both fetuses is the most important factor in determining the mode of delivery.</li>\r\n<li>If both twins are in cephalic presentation (which occurs in over 60% of twin pregnancies), normal vaginal delivery is usually preferred and safe, especially if the gestation is term and there are no additional complications (like growth restriction, discordance, or fetal distress).</li>\r\n<li>Cephalic-cephalic presentation offers the lowest risk during vaginal delivery because both babies can navigate the birth canal in the most favorable position.</li>\r\n<li>Obstetricians typically proceed with vaginal delivery under continuous monitoring, ensuring preparedness for emergency cesarean if needed.</li>\r\n</ul>\r\n<p><strong>Recommended delivery modes based on presentation:</strong></p><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250829d2e7f585-1587-4290-a1dd-87e4923e2f01.png\">\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>LSCS, vaginal (Option A):</strong> This implies a cesarean for twin A and vaginal for twin B, which is not practiced. The first twin's mode of delivery usually determines the approach.</p>\r\n<p><strong>Vaginal, LSCS (Option B)</strong>: A vaginal delivery for twin A followed by cesarean for twin B is extremely rare and usually avoided unless complications arise after delivery of the first twin.</p>\r\n<p><strong>LSCS for both (Option D):</strong> Cesarean section for both is unnecessary when both twins are in cephalic presentation unless other maternal or fetal indications are present.</p>\r\n<p><strong>Reference: </strong><a href=\"https://pubmed.ncbi.nlm.nih.gov/34454159/\">https://pubmed.ncbi.nlm.nih.gov/34454159/</a></p>",
      "correct_choice_id": 313,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 33,
      "choices": [
        {
          "id": 321,
          "text": "<p><span style=\"font-size:12.0pt;\">46XY</span></p>"
        },
        {
          "id": 322,
          "text": "<p><span style=\"font-size:12.0pt;\">46XX</span></p>"
        },
        {
          "id": 323,
          "text": "<p><span style=\"font-size:12.0pt;\">45XO</span></p>"
        },
        {
          "id": 324,
          "text": "<p><span style=\"font-size:12.0pt;\">47XXY</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A teenage girl presents with a history of primary amenorrhea, normal breast and pubic hair development with normal uterus and ovaries. On physical examination, an imperforate hymen is observed, as in the image given below. What karyotype analysis would you consider for further evaluation?<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250829349ddcab-bd68-4885-86c9-4613dfef24e0.png\"></span></p>",
      "unique_key": "DT1325124",
      "question_audio": null,
      "question_video": null,
      "map_id": 1325124,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>An imperforate hymen is a structural genital tract anomaly seen in phenotypically and genotypically normal females with a 46XX karyotype.</p>\r\n<ul>\r\n<li>Primary amenorrhea refers to the absence of menstruation by the age of 13 without secondary sexual characteristics or by 15 with normal secondary sexual development.</li>\r\n<li>This patient has normal breast and pubic hair development and normal uterus and ovaries, suggesting that hormonal pathways (hypothalamic-pituitary-ovarian axis) are intact.</li>\r\n<li>The presence of a bulging imperforate hymen is pathognomonic for cryptomenorrhea, where menstrual blood cannot exit due to hymenal obstruction, causing cyclic abdominal pain and hematocolpos.</li>\r\n<li>A 46XX karyotype confirms normal female chromosomal makeup.</li>\r\n<li>Since the patient has developed normal secondary sexual characteristics and internal genitalia, no chromosomal abnormality is suspected, and 46XX is the expected karyotype.</li>\r\n</ul>\r\n<p><strong>Causes of Primary Amenorrhea:</strong></p><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202508290cd32cc4-36ce-488f-9bb8-61ac8e5996ff.png\"><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250829919f66a6-6dd0-4f44-ba2f-f6082a735e09.png\">\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>46XY (Option A):</strong> This karyotype corresponds to a genotypic male. In Androgen Insensitivity Syndrome (AIS), a 46XY individual may appear phenotypically female with breast development but typically lacks a uterus and may present with a blind vaginal pouch-not an imperforate hymen.</p>\r\n<p><strong>45XO (Option C):</strong> Seen in Turner syndrome, characterized by primary amenorrhea, short stature, streak ovaries, and lack of secondary sexual characteristics. These patients usually have gonadal dysgenesis-not cryptomenorrhea or a normal uterus with an imperforate hymen.</p>\r\n<p><strong>47XXY (Option D):</strong> This karyotype indicates Klinefelter syndrome, a male disorder with tall stature, gynecomastia, and infertility-not associated with imperforate hymen or primary amenorrhea in females.</p>",
      "correct_choice_id": 322,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 34,
      "choices": [
        {
          "id": 331,
          "text": "<p><span style=\"font-size:12.0pt;\">Burn-Marshall Maneuver</span></p>"
        },
        {
          "id": 332,
          "text": "<p><span style=\"font-size:12.0pt;\">Lovset Maneuver</span></p>"
        },
        {
          "id": 333,
          "text": "<p><span style=\"font-size:12.0pt;\">Mauriceau-Smellie-Veit Maneuver</span></p>"
        },
        {
          "id": 334,
          "text": "<p><span style=\"font-size:12.0pt;\">None of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Identify the maneuver shown in the image.<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202508294b4a51ab-384b-46bc-a9e0-8820757eaad0.png\"></span></p>",
      "unique_key": "DT1325125",
      "question_audio": null,
      "question_video": null,
      "map_id": 1325125,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>Burn-Marshall Maneuver is used to deliver the after-coming head in breech presentations by letting the fetus hang and applying upward traction.</p>\r\n<ul>\r\n<li>The Burn-Marshall Maneuver (also known as Burns' maneuver) is employed during breech deliveries specifically to facilitate delivery of the after-coming head.<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250829af246dbf-6eac-40fd-9380-45bab30532fc.png\"></li>\r\n<li>In this maneuver, once the fetal body is delivered up to the shoulders, the fetus is allowed to hang by gravity until the nape of the neck becomes visible at the vulva.</li>\r\n<li>At this point, the fetal legs are gently elevated upwards toward the maternal abdomen, using the curvature of the birth canal and maternal pelvic outlet to aid in head flexion and delivery.</li>\r\n<li>It is a simple, gravity-assisted technique particularly useful when the fetal head is not entrapped.</li>\r\n<li>This maneuver contrasts with others like the Mauriceau-Smellie-Veit, which involves digital support of the fetal face and traction on the shoulders, and Lovset, which is used for the delivery of the shoulders rather than the head.</li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>Lovset Maneuver (Option B):</strong> Used to deliver shoulders in breech deliveries. The fetal body is rotated to bring each shoulder into an anterior position for easier delivery.</p><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250829f741d790-13d5-4e90-b710-cce18d1cb416.png\">\r\n<p><strong>Mauriceau-Smellie-Veit Maneuver (Option C):</strong> Used to deliver the after-coming head by placing the baby astride the forearm and applying traction using fingers in the baby's mouth and shoulder.</p><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250829c3c2bdc6-0854-4d1e-8eb0-d0eb2e9f1802.png\">",
      "correct_choice_id": 331,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 35,
      "choices": [
        {
          "id": 341,
          "text": "<p><span style=\"font-size:12.0pt;\">Degree 1</span></p>"
        },
        {
          "id": 342,
          "text": "<p><span style=\"font-size:12.0pt;\">Degree 2</span></p>"
        },
        {
          "id": 343,
          "text": "<p><span style=\"font-size:12.0pt;\">Degree 3</span></p>"
        },
        {
          "id": 344,
          "text": "<p><span style=\"font-size:12.0pt;\">Degree 4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Identify the degree of uterine prolapse.<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202508294eaaf8e6-51dc-4b4c-af26-c3d45f676839.png\"></span></p>",
      "unique_key": "DT1325126",
      "question_audio": null,
      "question_video": null,
      "map_id": 1325126,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>Degree 3 uterine prolapse is characterized by descent of the uterus such that it protrudes through the vaginal opening but does not extend entirely beyond the vulva.</p>\r\n<ul>\r\n<li>Uterine prolapse occurs when pelvic floor muscles and ligaments become weak and are no longer able to support the uterus, leading to its descent into or through the vagina.</li>\r\n<li>Prolapse is classified into four degrees:\r\n<ul>\r\n<li>1st Degree: Uterus descends into the upper two-thirds of the vagina. <strong>(Option A ruled out)</strong></li>\r\n<li>2nd Degree: Uterus reaches the vaginal introitus. <strong>(Options B ruled out)</strong></li>\r\n<li>3rd Degree: Uterus protrudes out of the introitus but remains partially within the vulva.</li>\r\n<li>4th Degree (Procidentia): Uterus is completely outside the vaginal canal. <strong>(Option D ruled out)</strong></li>\r\n</ul>\r\n</li>\r\n<li>In Degree 3, as seen in the case and image, the uterus bulges visibly through the vaginal introitus, often causing discomfort, a dragging sensation, or a visible mass.</li>\r\n</ul>\r\n<p><strong>Causes of uterine prolapse:</strong></p><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250829422a4c1e-b44d-420c-9848-e06945209f87.png\">",
      "correct_choice_id": 343,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 36,
      "choices": [
        {
          "id": 351,
          "text": "<p><span style=\"font-size:12.0pt;\">Switch to LMWH</span></p>"
        },
        {
          "id": 352,
          "text": "<p><span style=\"font-size:12.0pt;\">Immediate induction of labor</span></p>"
        },
        {
          "id": 353,
          "text": "<p><span style=\"font-size:12.0pt;\">Immediate LSCS (Lower Segment Caesarean Section)</span></p>"
        },
        {
          "id": 354,
          "text": "<p><span style=\"font-size:12.0pt;\">Continue the same</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 37-weeks pregnant woman with a mechanical prosthetic heart valve on warfarin presents for a routine antenatal check-up. She is asymptomatic and reports no bleeding or contractions.</span></p>",
      "unique_key": "DT1325127",
      "question_audio": null,
      "question_video": null,
      "map_id": 1325127,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>At term, warfarin should be switched to LMWH to reduce the risk of fetal and maternal bleeding during labor.</p>\r\n<ul>\r\n<li>Warfarin is teratogenic and crosses the placenta, especially dangerous during organogenesis in the first trimester and during delivery due to fetal intracranial hemorrhage.</li>\r\n<li>By 36-37 weeks of gestation, warfarin must be discontinued and replaced with LMWH to ensure safety for both mother and fetus in preparation for labor or cesarean section.</li>\r\n<li>For women with mechanical heart valves, anticoagulation must continue-but with a safer agent like LMWH, which does not cross the placenta and has a shorter half-life, allowing temporary discontinuation just before delivery (usually 6-12 hours).</li>\r\n<li>This strategy balances maternal protection from thrombosis while minimizing fetal/neonatal bleeding risks.</li>\r\n</ul>\r\n<p><strong>Summary Flowchart: Anticoagulation in Pregnancy with Mechanical Valves</strong></p>\r\n<p>First Trimester:</p>\r\n<ul>\r\n<li>LMWH (to avoid teratogenicity)</li>\r\n</ul>\r\n<p>Second Trimester:</p>\r\n<ul>\r\n<li>Warfarin (if &lt;5 mg/day, relatively safer)</li>\r\n</ul>\r\n<p>At 36-37 Weeks:</p>\r\n<ul>\r\n<li>Switch back to LMWH (to avoid bleeding during delivery)</li>\r\n</ul>\r\n<p>Postpartum:</p>\r\n<ul>\r\n<li>Restart warfarin after delivery\r\n<ul>\r\n<li>Regular monitoring (PT-INR for warfarin, anti-Xa for LMWH if needed) is essential throughout.</li>\r\n<li>Switching to LMWH near term is the best strategy to ensure both maternal protection and fetal safety during delivery.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>Immediate induction of labor (Option B):</strong> Induction without adjusting anticoagulation increases risk of hemorrhage. Anticoagulation needs to be optimized first before considering induction.</p>\r\n<p><strong>Immediate LSCS (Option C):</strong> C-section isn't indicated just for being on warfarin. Surgery would need anticoagulation to be managed (stop warfarin, use LMWH). Immediate LSCS without planning is risky.</p>\r\n<p><strong>Continue the same (Option D):</strong> Continuing warfarin at term is dangerous due to the risk of fetal bleeding, particularly intracranial hemorrhage during delivery.</p>",
      "correct_choice_id": 351,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 37,
      "choices": [
        {
          "id": 361,
          "text": "<p><span style=\"font-size:12.0pt;\">Prolapse</span></p>"
        },
        {
          "id": 362,
          "text": "<p><span style=\"font-size:12.0pt;\">Vulvar cancer</span></p>"
        },
        {
          "id": 363,
          "text": "<p><span style=\"font-size:12.0pt;\">Endometrial cancer</span></p>"
        },
        {
          "id": 364,
          "text": "<p><span style=\"font-size:12.0pt;\">Abruption placenta</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is this grid system used for?<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250829aaf6f192-f860-4147-ad1a-87bb12c022d7.png\"></span></p>",
      "unique_key": "DT1325128",
      "question_audio": null,
      "question_video": null,
      "map_id": 1325128,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>The POP-Q grid system is a standardized method used to assess the severity and classification of pelvic organ prolapse.</p>\r\n<ul>\r\n<li>The Pelvic Organ Prolapse Quantification (POP-Q) system is the most widely accepted and standardized method for evaluating and documenting pelvic organ prolapse.</li>\r\n<li>It uses specific reference points on the vaginal walls and cervix in relation to the hymen to assign a prolapse stage from 0 to IV.</li>\r\n<li>The system allows objective, reproducible measurements that help clinicians compare prolapse severity over time or pre- and post-treatment.</li>\r\n<li>POP-Q Staging:</li>\r\n<li>Stage 0: No prolapse.\r\n<ul>\r\n<li>Stage I: Most distal portion of prolapse is &gt;1 cm above the hymen.</li>\r\n<li>Stage II: Leading edge of prolapse is &le;1 cm above or below the hymen.</li>\r\n<li>Stage III: Leading edge is &gt;1 cm below hymen but not complete eversion.</li>\r\n<li>Stage IV: Complete eversion of the total vaginal length.</li>\r\n</ul>\r\n</li>\r\n<li>This system improves communication between providers and guides surgical or conservative management of prolapse.<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250829debc34ca-1df4-4959-a01b-b79d8d17d4fe.png\"><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250829342dfbf0-3b70-423a-8bc0-8c6d847549e4.png\"></li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>Vulvar cancer (Option B):</strong> This is staged using FIGO or TNM systems, not POP-Q.</p>\r\n<p><strong>Endometrial cancer (Option C):</strong> Endometrial cancer staging is done surgically based on FIGO criteria, not prolapse quantification systems.</p>\r\n<p><strong>Abruption placenta (Option D):</strong> Abruptio placentae is a clinical obstetric emergency assessed based on symptoms and imaging, not by any pelvic organ measurement grid.</p>",
      "correct_choice_id": 361,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}